A Study to Determine the Absolute Bioavailability of BIIB122/DNL151 in Healthy Subjects

NCT05005338 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: BIIB122 (DNL151)
DRUG: [14C] BIIB122 ([14C] DNL151)

Sponsor

Biogen

Collaborators

[object Object]